Technological innovation has chipped away at the limitations of the medical profession for centuries, but NIRAMAI believes that AI advancements will be the industry gamechanger. The Bangalore-based deep-tech start-up’s acronymic title stands for Non-Invasive Risk Assessment with Machine Intelligence. It is dedicated to fighting breast cancer, which is the leading cause of cancer deaths in women. The World Health Organisation warns that one in every 12 women is at risk of breast abnormalities at some stage of life, and early diagnosis is crucial. NIRAMAI focuses on the key limitations of traditional detection methods. MRI machinery is cumbersome and expensive, X-ray scans cause incremental, cumulative health damage, and the entire process is at-best uncomfortable and embarrassing for the patient. The company addresses these shortfalls with an AI-powered solution. It has developed portable diagnostic cubicles that promise privacy and accuracy. NIRAMAI stands behind its product and procedures, which have delivered excellent results in reducing screening costs while amplifying detection parameters. It uses patented AI and machine-learning algorithms to create thermal-analytics-based diagnostic tools. The multi-use system enables early-stage detection of health conditions, as well as large-scale screenings. The company is proud to see that the investments it has made in research, data and technology are paying dividends in terms of revenue as well as health outcomes. The CFI.co judging panel presents NIRAMAI, a patent holder in 10 global territories, with the 2021 award for Best Medical Device Innovator (India).
IBM has built a long-standing reputation for its strong governance framework and transparent communication with…
IDFC FIRST Bank has redefined digital banking in India by blending advanced technologies with a…
ABN AMRO MeesPierson demonstrates a forward-thinking and holistic approach to private banking, placing the needs…
SegurCaixa Adeslas has demonstrated exceptional resilience and strategic focus in a year marked by global…
Berenberg, Germany’s oldest privately owned bank, has cultivated a legacy of excellence in strategic investment…
AXA IM Select continues to redefine the multi-manager investment landscape with a robust and diversified…